A PCP’s perspective on the role of GLP-1 medications A PCP’s perspective on the role of GLP-1 medications GLP-1 receptor agonists are among the most innovative and transformative medications to come on…
Tirzepatide may not raise risk for diabetic retinopathy
Tirzepatide and Diabetic Retinopathy: Reassuring Signals for Type 1 Diabetes Patients Tirzepatide and Diabetic Retinopathy: Reassuring Signals for Type 1 Diabetes Patients An analysis by [Your Name/Medical Doctor Persona] Recent data from…
Physician reliability increased for gait analysis interpretation
Physician Reliability in Gait Analysis Interpretation: A New Era for Objective Pediatric Care Physician Reliability in Gait Analysis Interpretation: A New Era for Objective Pediatric Care In the complex landscape of pediatric…
Treatment to lower blood pressure reduces recurrent stroke risk
Intensive Blood Pressure Control: A Game Changer in Post-ICH Stroke Prevention Intensive Blood Pressure Control: A Game Changer in Post-ICH Stroke Prevention By Dr. Anya Sharma, MD | October 26, 2023 Main…
Interventional glaucoma takes the lead for vision preservation
Interventional Glaucoma: A Paradigm Shift for Sustainable Vision Preservation Interventional Glaucoma: A Paradigm Shift for Sustainable Vision Preservation This analysis is inspired by the recent insights highlighted in the Healio Exclusive, “Interventional…
ACC issues expert consensus pathway for HFpEF care
Navigating the Evolving Landscape: ACC’s Updated HFpEF Pathway Reshapes Care Navigating the Evolving Landscape: ACC’s Updated HFpEF Pathway Reshapes Care As clinicians on the front lines, we constantly strive to deliver the…
Virtual smoking cessation program benefits patients with cancer
Revolutionizing Cancer Care: The Power of Virtual Smoking Cessation Programs Revolutionizing Cancer Care: The Power of Virtual Smoking Cessation Programs As medical professionals, we continually seek innovative strategies to enhance patient care…
GLP-1 reduces rates of post-bariatric hypoglycemia
Avexitide’s Breakthrough: A Targeted Approach to Post-Bariatric Hypoglycemia Avexitide’s Breakthrough: A Targeted Approach to Post-Bariatric Hypoglycemia A once-daily GLP-1 receptor agonist decreased events of level 2 and level 3 hypoglycemia for adults…
Managing dermatologic symptoms with testosterone therapy for women
Managing Dermatologic Symptoms with Testosterone Therapy for Women: A Clinical Perspective Managing Dermatologic Symptoms with Testosterone Therapy for Women: A Clinical Perspective As a medical doctor, I often encounter the intricate web…
Eating protein not tied to kidney decline for adults without CKD
Reassessing Dietary Protein and Kidney Health: A New Perspective for Adults Without CKD Reassessing Dietary Protein and Kidney Health: A New Perspective for Adults Without CKD For years, dietary advice has often…
Duravyu misses phase 3 primary endpoint in wet AMD
Duravyu Phase 3 LUGANO Trial: A Deeper Dive into Wet AMD Treatment Paradigms Duravyu’s Phase 3 LUGANO Trial: Navigating Nuance in Wet AMD Treatment Innovation The landscape of wet age-related macular degeneration…
Drug costs for federally sponsored trials are substantial
Unpacking the High Cost of Cancer Clinical Trials: A Physician’s Perspective on Drug Expenditure Navigating the Escalating Price Tag of Cancer Research: A Call for Strategic Investment New data shines a critical…
Allograft results in epithelialization in nonhealing corneal diseases
A New Horizon for Corneal Healing: Decellularized Descemet’s Membrane Allograft Shows Promise A New Horizon for Corneal Healing: Decellularized Descemet’s Membrane Allograft Shows Promise By [Your Name/Medical Title, e.g., Dr. Anya Sharma,…
Oculis to acquire development, commercial rights for privosegtor
Oculis’ Acquisition of Privosegtor: A Deep Dive into Neuroprotection for Optic Neuritis Oculis’ Acquisition of Privosegtor: A Deep Dive into Neuroprotection for Optic Neuritis The recent announcement of Oculis’ intent to acquire…
EHR nudges can improve guideline-concordant cancer care
EHR Nudges: A Game-Changer for Guideline-Concordant Cancer Care EHR Nudges: A Game-Changer for Guideline-Concordant Cancer Care As a physician navigating the complexities of modern oncology, the integration of technology with clinical practice…